nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB11—Rosuvastatin—atherosclerosis	0.283	0.329	CbGbCtD
Clofazimine—ABCB11—Pravastatin—atherosclerosis	0.258	0.299	CbGbCtD
Clofazimine—ABCB1—Ezetimibe—atherosclerosis	0.0486	0.0564	CbGbCtD
Clofazimine—ABCB1—Simvastatin—atherosclerosis	0.0452	0.0524	CbGbCtD
Clofazimine—ABCB1—Pravastatin—atherosclerosis	0.0442	0.0513	CbGbCtD
Clofazimine—ABCB1—Lovastatin—atherosclerosis	0.0442	0.0513	CbGbCtD
Clofazimine—CYP3A4—Rosuvastatin—atherosclerosis	0.0291	0.0338	CbGbCtD
Clofazimine—CYP3A4—Ezetimibe—atherosclerosis	0.0291	0.0338	CbGbCtD
Clofazimine—CYP3A4—Simvastatin—atherosclerosis	0.0271	0.0314	CbGbCtD
Clofazimine—CYP3A4—Lovastatin—atherosclerosis	0.0265	0.0307	CbGbCtD
Clofazimine—CYP3A4—Pravastatin—atherosclerosis	0.0265	0.0307	CbGbCtD
Clofazimine—Hepatomegaly—Niacin—atherosclerosis	0.00257	0.0331	CcSEcCtD
Clofazimine—Skin discolouration—Niacin—atherosclerosis	0.00202	0.0259	CcSEcCtD
Clofazimine—Depression—Rosuvastatin—atherosclerosis	0.00139	0.018	CcSEcCtD
Clofazimine—Jaundice—Rosuvastatin—atherosclerosis	0.00136	0.0176	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00132	0.017	CcSEcCtD
Clofazimine—Eosinophilia—Lovastatin—atherosclerosis	0.00132	0.0169	CcSEcCtD
Clofazimine—Eosinophilia—Ezetimibe—atherosclerosis	0.00129	0.0166	CcSEcCtD
Clofazimine—Hepatitis—Rosuvastatin—atherosclerosis	0.00126	0.0162	CcSEcCtD
Clofazimine—Eosinophilia—Simvastatin—atherosclerosis	0.00123	0.0159	CcSEcCtD
Clofazimine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00121	0.0156	CcSEcCtD
Clofazimine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00119	0.0153	CcSEcCtD
Clofazimine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00114	0.0146	CcSEcCtD
Clofazimine—Jaundice—Ezetimibe—atherosclerosis	0.00113	0.0146	CcSEcCtD
Clofazimine—Eosinophilia—Pravastatin—atherosclerosis	0.00111	0.0143	CcSEcCtD
Clofazimine—Depression—Simvastatin—atherosclerosis	0.00111	0.0142	CcSEcCtD
Clofazimine—Jaundice—Simvastatin—atherosclerosis	0.00108	0.0139	CcSEcCtD
Clofazimine—Hepatitis—Lovastatin—atherosclerosis	0.00106	0.0137	CcSEcCtD
Clofazimine—Hepatitis—Ezetimibe—atherosclerosis	0.00104	0.0134	CcSEcCtD
Clofazimine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00103	0.0132	CcSEcCtD
Clofazimine—Weight decreased—Pravastatin—atherosclerosis	0.00102	0.0131	CcSEcCtD
Clofazimine—Depression—Pravastatin—atherosclerosis	0.001	0.0129	CcSEcCtD
Clofazimine—Hepatitis—Simvastatin—atherosclerosis	0.000996	0.0128	CcSEcCtD
Clofazimine—Jaundice—Niacin—atherosclerosis	0.000993	0.0128	CcSEcCtD
Clofazimine—Jaundice—Pravastatin—atherosclerosis	0.000977	0.0126	CcSEcCtD
Clofazimine—Hepatitis—Niacin—atherosclerosis	0.000914	0.0118	CcSEcCtD
Clofazimine—Hepatitis—Pravastatin—atherosclerosis	0.0009	0.0116	CcSEcCtD
Clofazimine—Visual impairment—Niacin—atherosclerosis	0.000881	0.0113	CcSEcCtD
Clofazimine—Visual impairment—Pravastatin—atherosclerosis	0.000867	0.0112	CcSEcCtD
Clofazimine—Anaemia—Ezetimibe—atherosclerosis	0.00084	0.0108	CcSEcCtD
Clofazimine—Anaemia—Simvastatin—atherosclerosis	0.000801	0.0103	CcSEcCtD
Clofazimine—Constipation—Rosuvastatin—atherosclerosis	0.000763	0.00982	CcSEcCtD
Clofazimine—Anaemia—Pravastatin—atherosclerosis	0.000724	0.00932	CcSEcCtD
Clofazimine—Anorexia—Lovastatin—atherosclerosis	0.000721	0.00928	CcSEcCtD
Clofazimine—Oedema—Simvastatin—atherosclerosis	0.000707	0.0091	CcSEcCtD
Clofazimine—Anorexia—Simvastatin—atherosclerosis	0.000674	0.00868	CcSEcCtD
Clofazimine—Decreased appetite—Lovastatin—atherosclerosis	0.000657	0.00846	CcSEcCtD
Clofazimine—Fatigue—Lovastatin—atherosclerosis	0.000652	0.00839	CcSEcCtD
Clofazimine—Oedema—Niacin—atherosclerosis	0.000649	0.00836	CcSEcCtD
Clofazimine—Constipation—Lovastatin—atherosclerosis	0.000647	0.00832	CcSEcCtD
Clofazimine—Decreased appetite—Ezetimibe—atherosclerosis	0.000645	0.0083	CcSEcCtD
Clofazimine—Asthenia—Rosuvastatin—atherosclerosis	0.00064	0.00824	CcSEcCtD
Clofazimine—Oedema—Pravastatin—atherosclerosis	0.000639	0.00823	CcSEcCtD
Clofazimine—Fatigue—Ezetimibe—atherosclerosis	0.000639	0.00823	CcSEcCtD
Clofazimine—Constipation—Ezetimibe—atherosclerosis	0.000634	0.00816	CcSEcCtD
Clofazimine—Pruritus—Rosuvastatin—atherosclerosis	0.000631	0.00813	CcSEcCtD
Clofazimine—Anorexia—Niacin—atherosclerosis	0.000619	0.00797	CcSEcCtD
Clofazimine—Decreased appetite—Simvastatin—atherosclerosis	0.000615	0.00791	CcSEcCtD
Clofazimine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00061	0.00786	CcSEcCtD
Clofazimine—Fatigue—Simvastatin—atherosclerosis	0.00061	0.00785	CcSEcCtD
Clofazimine—Anorexia—Pravastatin—atherosclerosis	0.00061	0.00785	CcSEcCtD
Clofazimine—Constipation—Simvastatin—atherosclerosis	0.000605	0.00779	CcSEcCtD
Clofazimine—Body temperature increased—Lovastatin—atherosclerosis	0.000598	0.00769	CcSEcCtD
Clofazimine—Dizziness—Rosuvastatin—atherosclerosis	0.00059	0.0076	CcSEcCtD
Clofazimine—Body temperature increased—Ezetimibe—atherosclerosis	0.000586	0.00755	CcSEcCtD
Clofazimine—Somnolence—Niacin—atherosclerosis	0.000577	0.00743	CcSEcCtD
Clofazimine—Decreased appetite—Niacin—atherosclerosis	0.000565	0.00727	CcSEcCtD
Clofazimine—Rash—Rosuvastatin—atherosclerosis	0.000563	0.00724	CcSEcCtD
Clofazimine—Dermatitis—Rosuvastatin—atherosclerosis	0.000562	0.00724	CcSEcCtD
Clofazimine—Body temperature increased—Simvastatin—atherosclerosis	0.000559	0.0072	CcSEcCtD
Clofazimine—Headache—Rosuvastatin—atherosclerosis	0.000559	0.0072	CcSEcCtD
Clofazimine—Decreased appetite—Pravastatin—atherosclerosis	0.000556	0.00716	CcSEcCtD
Clofazimine—Fatigue—Pravastatin—atherosclerosis	0.000551	0.0071	CcSEcCtD
Clofazimine—Constipation—Pravastatin—atherosclerosis	0.000547	0.00704	CcSEcCtD
Clofazimine—Asthenia—Lovastatin—atherosclerosis	0.000543	0.00698	CcSEcCtD
Clofazimine—Pruritus—Lovastatin—atherosclerosis	0.000535	0.00689	CcSEcCtD
Clofazimine—Asthenia—Ezetimibe—atherosclerosis	0.000532	0.00685	CcSEcCtD
Clofazimine—Nausea—Rosuvastatin—atherosclerosis	0.00053	0.00682	CcSEcCtD
Clofazimine—Pruritus—Ezetimibe—atherosclerosis	0.000525	0.00675	CcSEcCtD
Clofazimine—Diarrhoea—Lovastatin—atherosclerosis	0.000517	0.00666	CcSEcCtD
Clofazimine—Body temperature increased—Niacin—atherosclerosis	0.000513	0.00661	CcSEcCtD
Clofazimine—Asthenia—Simvastatin—atherosclerosis	0.000507	0.00653	CcSEcCtD
Clofazimine—Diarrhoea—Ezetimibe—atherosclerosis	0.000507	0.00653	CcSEcCtD
Clofazimine—Body temperature increased—Pravastatin—atherosclerosis	0.000505	0.00651	CcSEcCtD
Clofazimine—Pruritus—Simvastatin—atherosclerosis	0.0005	0.00644	CcSEcCtD
Clofazimine—Dizziness—Lovastatin—atherosclerosis	0.0005	0.00644	CcSEcCtD
Clofazimine—Dizziness—Ezetimibe—atherosclerosis	0.00049	0.00631	CcSEcCtD
Clofazimine—Diarrhoea—Simvastatin—atherosclerosis	0.000484	0.00623	CcSEcCtD
Clofazimine—Vomiting—Lovastatin—atherosclerosis	0.000481	0.00619	CcSEcCtD
Clofazimine—Rash—Lovastatin—atherosclerosis	0.000477	0.00614	CcSEcCtD
Clofazimine—Dermatitis—Lovastatin—atherosclerosis	0.000476	0.00613	CcSEcCtD
Clofazimine—Headache—Lovastatin—atherosclerosis	0.000474	0.0061	CcSEcCtD
Clofazimine—Vomiting—Ezetimibe—atherosclerosis	0.000472	0.00607	CcSEcCtD
Clofazimine—Dizziness—Simvastatin—atherosclerosis	0.000468	0.00602	CcSEcCtD
Clofazimine—Rash—Ezetimibe—atherosclerosis	0.000468	0.00602	CcSEcCtD
Clofazimine—Dermatitis—Ezetimibe—atherosclerosis	0.000467	0.00601	CcSEcCtD
Clofazimine—Asthenia—Niacin—atherosclerosis	0.000466	0.006	CcSEcCtD
Clofazimine—Headache—Ezetimibe—atherosclerosis	0.000465	0.00598	CcSEcCtD
Clofazimine—Pruritus—Niacin—atherosclerosis	0.000459	0.00591	CcSEcCtD
Clofazimine—Asthenia—Pravastatin—atherosclerosis	0.000459	0.00591	CcSEcCtD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000454	0.00747	CbGpPWpGaD
Clofazimine—Pruritus—Pravastatin—atherosclerosis	0.000452	0.00582	CcSEcCtD
Clofazimine—Vomiting—Simvastatin—atherosclerosis	0.00045	0.00579	CcSEcCtD
Clofazimine—Nausea—Lovastatin—atherosclerosis	0.000449	0.00578	CcSEcCtD
Clofazimine—Rash—Simvastatin—atherosclerosis	0.000446	0.00574	CcSEcCtD
Clofazimine—Dermatitis—Simvastatin—atherosclerosis	0.000446	0.00574	CcSEcCtD
Clofazimine—Diarrhoea—Niacin—atherosclerosis	0.000444	0.00572	CcSEcCtD
Clofazimine—Headache—Simvastatin—atherosclerosis	0.000443	0.0057	CcSEcCtD
Clofazimine—Nausea—Ezetimibe—atherosclerosis	0.000441	0.00567	CcSEcCtD
Clofazimine—Diarrhoea—Pravastatin—atherosclerosis	0.000438	0.00563	CcSEcCtD
Clofazimine—Dizziness—Niacin—atherosclerosis	0.000429	0.00553	CcSEcCtD
Clofazimine—Dizziness—Pravastatin—atherosclerosis	0.000423	0.00544	CcSEcCtD
Clofazimine—Nausea—Simvastatin—atherosclerosis	0.00042	0.00541	CcSEcCtD
Clofazimine—Vomiting—Niacin—atherosclerosis	0.000413	0.00532	CcSEcCtD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000411	0.00677	CbGpPWpGaD
Clofazimine—Rash—Niacin—atherosclerosis	0.000409	0.00527	CcSEcCtD
Clofazimine—Dermatitis—Niacin—atherosclerosis	0.000409	0.00527	CcSEcCtD
Clofazimine—Headache—Niacin—atherosclerosis	0.000407	0.00524	CcSEcCtD
Clofazimine—Vomiting—Pravastatin—atherosclerosis	0.000407	0.00523	CcSEcCtD
Clofazimine—Rash—Pravastatin—atherosclerosis	0.000403	0.00519	CcSEcCtD
Clofazimine—Dermatitis—Pravastatin—atherosclerosis	0.000403	0.00519	CcSEcCtD
Clofazimine—Headache—Pravastatin—atherosclerosis	0.000401	0.00516	CcSEcCtD
Clofazimine—Nausea—Niacin—atherosclerosis	0.000386	0.00497	CcSEcCtD
Clofazimine—Nausea—Pravastatin—atherosclerosis	0.00038	0.00489	CcSEcCtD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000356	0.00586	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000345	0.00567	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000336	0.00552	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000316	0.00519	CbGpPWpGaD
Clofazimine—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000282	0.00465	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000274	0.0045	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000274	0.0045	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000261	0.0043	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000258	0.00424	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000241	0.00397	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000239	0.00393	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000238	0.00392	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000216	0.00356	CbGpPWpGaD
Clofazimine—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000214	0.00352	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000212	0.0035	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000212	0.00348	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IL17A—atherosclerosis	0.000207	0.0034	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000203	0.00335	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000203	0.00335	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.0002	0.00328	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000197	0.00325	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000196	0.00323	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000196	0.00322	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CD40—atherosclerosis	0.000183	0.00301	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000181	0.00298	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.000174	0.00286	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000172	0.00283	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000172	0.00283	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000172	0.00283	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000172	0.00283	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00017	0.00279	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	0.000168	0.00276	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	0.000164	0.0027	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000164	0.0027	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000157	0.00259	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000151	0.00249	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—LDLRAP1—atherosclerosis	0.000149	0.00246	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000147	0.00242	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000146	0.0024	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PLTP—atherosclerosis	0.000141	0.00231	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	0.00014	0.00231	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IL10—atherosclerosis	0.00014	0.00231	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	0.000133	0.0022	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—FASLG—atherosclerosis	0.000131	0.00215	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00013	0.00214	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000129	0.00213	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000129	0.00212	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000126	0.00207	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	0.000124	0.00205	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ABCG8—atherosclerosis	0.000122	0.00201	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—LTA4H—atherosclerosis	0.000122	0.00201	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000122	0.002	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00012	0.00198	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000118	0.00195	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000114	0.00187	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000112	0.00185	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000111	0.00182	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	0.000105	0.00172	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000104	0.00171	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000102	0.00169	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000101	0.00167	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	9.7e-05	0.0016	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ABCG1—atherosclerosis	9.63e-05	0.00159	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	9.3e-05	0.00153	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—FABP4—atherosclerosis	9.05e-05	0.00149	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—LCAT—atherosclerosis	9.05e-05	0.00149	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	8.97e-05	0.00148	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOA4—atherosclerosis	8.89e-05	0.00146	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP7A1—atherosclerosis	8.73e-05	0.00144	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	8.32e-05	0.00137	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IFNG—atherosclerosis	8.25e-05	0.00136	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP27A1—atherosclerosis	8.07e-05	0.00133	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.94e-05	0.00131	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.75e-05	0.00128	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	7.68e-05	0.00126	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOA2—atherosclerosis	7.65e-05	0.00126	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ALOX15—atherosclerosis	7.65e-05	0.00126	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PLA2G2A—atherosclerosis	7.65e-05	0.00126	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ALOX5AP—atherosclerosis	7.65e-05	0.00126	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ABCG5—atherosclerosis	7.56e-05	0.00124	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.55e-05	0.00124	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IL1B—atherosclerosis	7.36e-05	0.00121	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	7.35e-05	0.00121	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—LPA—atherosclerosis	7.3e-05	0.0012	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	7.23e-05	0.00119	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	7.2e-05	0.00118	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—BGN—atherosclerosis	7.07e-05	0.00116	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.02e-05	0.00116	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOA5—atherosclerosis	7e-05	0.00115	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.8e-05	0.00112	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PLA2G1B—atherosclerosis	6.74e-05	0.00111	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	6.66e-05	0.0011	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.66e-05	0.0011	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.6e-05	0.00109	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.58e-05	0.00108	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ALOX5—atherosclerosis	6.51e-05	0.00107	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	6.44e-05	0.00106	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	6.23e-05	0.00103	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.01e-05	0.000989	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	5.99e-05	0.000986	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—NAMPT—atherosclerosis	5.83e-05	0.00096	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.8e-05	0.000955	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—LIPC—atherosclerosis	5.8e-05	0.000954	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	5.77e-05	0.000949	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOC3—atherosclerosis	5.76e-05	0.000948	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—LDLR—atherosclerosis	5.73e-05	0.000943	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	5.72e-05	0.000942	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CETP—atherosclerosis	5.59e-05	0.000921	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	5.44e-05	0.000896	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—SCARB1—atherosclerosis	5.36e-05	0.000882	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—TNF—atherosclerosis	5.34e-05	0.000879	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—LDLRAP1—atherosclerosis	5.34e-05	0.000879	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.22e-05	0.000858	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—HMGCR—atherosclerosis	5.06e-05	0.000833	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PLTP—atherosclerosis	5.02e-05	0.000827	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	4.71e-05	0.000775	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.64e-05	0.000764	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	4.59e-05	0.000756	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.58e-05	0.000753	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.56e-05	0.000751	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ABCA1—atherosclerosis	4.51e-05	0.000742	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ABCG8—atherosclerosis	4.35e-05	0.000717	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—LTA4H—atherosclerosis	4.35e-05	0.000717	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	4.27e-05	0.000703	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	3.91e-05	0.000643	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—HMOX1—atherosclerosis	3.87e-05	0.000637	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.76e-05	0.000619	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOB—atherosclerosis	3.71e-05	0.00061	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GSTM1—atherosclerosis	3.6e-05	0.000593	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—LPL—atherosclerosis	3.54e-05	0.000582	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GPX1—atherosclerosis	3.45e-05	0.000568	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ABCG1—atherosclerosis	3.44e-05	0.000567	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	3.39e-05	0.000558	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CD36—atherosclerosis	3.36e-05	0.000553	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	3.33e-05	0.000548	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.29e-05	0.000542	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—LCAT—atherosclerosis	3.24e-05	0.000533	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—FABP4—atherosclerosis	3.24e-05	0.000533	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	3.2e-05	0.000526	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—MTHFR—atherosclerosis	3.19e-05	0.000524	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOA4—atherosclerosis	3.18e-05	0.000523	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PPARA—atherosclerosis	3.13e-05	0.000514	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP7A1—atherosclerosis	3.12e-05	0.000514	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PLTP—atherosclerosis	3.09e-05	0.000509	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	3.08e-05	0.000506	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—AGT—atherosclerosis	3.03e-05	0.000498	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOE—atherosclerosis	2.97e-05	0.000488	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.95e-05	0.000486	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CAV1—atherosclerosis	2.94e-05	0.000484	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOA1—atherosclerosis	2.93e-05	0.000483	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.91e-05	0.000479	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.88e-05	0.000475	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.83e-05	0.000465	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.82e-05	0.000465	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ALOX15—atherosclerosis	2.73e-05	0.00045	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.73e-05	0.00045	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOA2—atherosclerosis	2.73e-05	0.00045	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.73e-05	0.00045	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ABCG5—atherosclerosis	2.7e-05	0.000445	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.68e-05	0.000442	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.68e-05	0.000442	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PIK3CG—atherosclerosis	2.68e-05	0.000441	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.64e-05	0.000434	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—LPA—atherosclerosis	2.61e-05	0.000429	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PPARG—atherosclerosis	2.58e-05	0.000425	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—INS—atherosclerosis	2.53e-05	0.000417	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—BGN—atherosclerosis	2.53e-05	0.000416	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOA5—atherosclerosis	2.5e-05	0.000412	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	2.41e-05	0.000396	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.38e-05	0.000393	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ALOX5—atherosclerosis	2.32e-05	0.000383	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ALB—atherosclerosis	2.32e-05	0.000382	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.24e-05	0.000368	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—NOS3—atherosclerosis	2.22e-05	0.000366	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.12e-05	0.000349	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—NAMPT—atherosclerosis	2.09e-05	0.000343	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—LIPC—atherosclerosis	2.07e-05	0.000341	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOC3—atherosclerosis	2.06e-05	0.000339	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—LDLR—atherosclerosis	2.05e-05	0.000337	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PTGS2—atherosclerosis	2.03e-05	0.000334	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CETP—atherosclerosis	2e-05	0.000329	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.99e-05	0.000328	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.99e-05	0.000328	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.96e-05	0.000323	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.96e-05	0.000322	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.92e-05	0.000316	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—SCARB1—atherosclerosis	1.91e-05	0.000315	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—HMGCR—atherosclerosis	1.81e-05	0.000298	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.78e-05	0.000292	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.77e-05	0.000292	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.68e-05	0.000277	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.68e-05	0.000277	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.68e-05	0.000277	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.68e-05	0.000277	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.66e-05	0.000274	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ABCA1—atherosclerosis	1.61e-05	0.000265	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—LPA—atherosclerosis	1.61e-05	0.000265	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—BGN—atherosclerosis	1.56e-05	0.000256	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.54e-05	0.000254	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.48e-05	0.000244	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.43e-05	0.000236	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—HMOX1—atherosclerosis	1.38e-05	0.000228	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOB—atherosclerosis	1.32e-05	0.000218	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GSTM1—atherosclerosis	1.29e-05	0.000212	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.28e-05	0.000211	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.28e-05	0.00021	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.27e-05	0.000209	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—LPL—atherosclerosis	1.26e-05	0.000208	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.26e-05	0.000208	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GPX1—atherosclerosis	1.23e-05	0.000203	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CETP—atherosclerosis	1.23e-05	0.000203	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CD36—atherosclerosis	1.2e-05	0.000198	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.18e-05	0.000194	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—MTHFR—atherosclerosis	1.14e-05	0.000187	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PPARA—atherosclerosis	1.12e-05	0.000184	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.11e-05	0.000183	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—AGT—atherosclerosis	1.08e-05	0.000178	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOE—atherosclerosis	1.06e-05	0.000174	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CAV1—atherosclerosis	1.05e-05	0.000173	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOA1—atherosclerosis	1.05e-05	0.000172	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—AKT1—atherosclerosis	1.02e-05	0.000168	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.93e-06	0.000163	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PIK3CG—atherosclerosis	9.57e-06	0.000157	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PPARG—atherosclerosis	9.23e-06	0.000152	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—INS—atherosclerosis	9.06e-06	0.000149	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—HMOX1—atherosclerosis	8.52e-06	0.00014	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ALB—atherosclerosis	8.3e-06	0.000137	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOB—atherosclerosis	8.16e-06	0.000134	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—NOS3—atherosclerosis	7.94e-06	0.000131	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.94e-06	0.000131	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—LPL—atherosclerosis	7.79e-06	0.000128	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GPX1—atherosclerosis	7.6e-06	0.000125	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CD36—atherosclerosis	7.4e-06	0.000122	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PTGS2—atherosclerosis	7.26e-06	0.00012	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.01e-06	0.000115	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PPARA—atherosclerosis	6.88e-06	0.000113	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—AGT—atherosclerosis	6.67e-06	0.00011	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOE—atherosclerosis	6.53e-06	0.000107	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CAV1—atherosclerosis	6.47e-06	0.000106	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOA1—atherosclerosis	6.46e-06	0.000106	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.89e-06	9.7e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PPARG—atherosclerosis	5.69e-06	9.36e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—INS—atherosclerosis	5.58e-06	9.18e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ALB—atherosclerosis	5.11e-06	8.42e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—NOS3—atherosclerosis	4.89e-06	8.05e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.47e-06	7.36e-05	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—AKT1—atherosclerosis	3.65e-06	6.01e-05	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—AKT1—atherosclerosis	2.25e-06	3.7e-05	CbGpPWpGaD
